论文信息 - Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment - 字舞流文

Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment

D. de Jong | T. Mutis | M. Roemer | S. Zweegman | Hilma J. van der Horst | H. F. van Essen | D. Berry | E. Breij | M. Chamuleau | I. Hiemstra | N. Hijmering | A. D. de Jonge | Anne T Gelderloos | A. de Jonge | Anne T. Gelderloos